Centessa Pharmaceuticals plc 4/A SEC Filings

Filed On	Filing
16 Mar 2026	Form 4/A: Anderson Karen M., Chief People Officer Received 109,398 shares by exercise or conversion ($436K) · Sold 120,029 shares ($3.15M)
23 Nov 2022	Form 4/A: Templeman Thomas, Chief Technology Officer Holds 140,250 shares of Ordinary Shares
23 Nov 2022	Form 4/A: Grainger David J, Chief Innovation Officer Holds 913,756 shares of Ordinary Shares
23 Nov 2022	Form 4/A: Shahidi Javad, Chief Medical Officer Holds 165,000 shares of Ordinary Shares
23 Nov 2022	Form 4/A: Weinhoff Gregory M, Chief Financial Officer Holds 240,000 shares of Ordinary Shares
23 Nov 2022	Form 4/A: Yver Antoine, EVP & Chairman of Development Sold 9,500 shares ($37.1K)
23 Nov 2022	Form 4/A: Hussain Iqbal J, General Counsel Holds 163,000 shares of Ordinary Shares
23 Nov 2022	Form 4/A: Chao David M, Chief Administrative Officer Holds 230,500 shares of Ordinary Shares
23 Nov 2022	Form 4/A: Bush Tia L, Chief Quality Officer Holds 140,000 shares of Ordinary Shares

Comments